U

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

VIE MSAT Lab Associate Scientist

Bioprocess & BiomanufacturingUpdated on Nov 14
Full-timeBraine-l'Alleud, BelgiumNo salary listed

About the Job

Requirements

  • A Bachelor's or Master's degree in biology, biotechnology, chemical engineering, or a related discipline is required.
  • Strong problem-solving and communication skills are required.
  • Fluency in English is required.
  • At least a basic level of French is required.
  • Candidates must be between 18 and 28 years old, hold the nationality of a member country of the European Economic Area, and must not have worked or lived in the country where the assignment takes place.
  • Candidates must be available to devote themselves full-time to the assignment.
  • French nationals or dual French nationals must be compliant with French national service obligations and have a Numéro Identifiant Défense.
  • Candidates must have a clean criminal record.

Responsibilities

  • Conduct downstream processing studies to build process understanding.
  • Provide laboratory support for technology transfers, process validations, manufacturing operations, and necessary deviation investigations, including appropriate DSP and analytical experiments in MSAT.
  • Perform product quality analysis on cell culture and downstream process samples using multiple techniques.
  • Plan and schedule DSP and analytical activities.
  • Support the implementation and transfer of analytical methods into the MSAT laboratory for late-stage and commercial products.
  • Establish a small-scale DSP model in the MSAT laboratory for commercial products using chromatography and tangential flow filtration.

Desired Qualifications

  • Experience in downstream processing (DSP) and/or analytics is an advantage.
  • Laboratory experience is an advantage.

About the Company

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

UCB Pharma focuses on developing treatments for severe diseases in neurology and immunology. It discovers, develops, and commercializes novel molecules and generates products aimed at improving patient lives. The company works by researching and developing therapies, integrating patient insights to guide innovation, and investing over a quarter of revenue into scientific research. Its global presence (about 9,000 employees across 40 countries) and €5.3 billion 2023 revenue reflect its scale and commitment to bringing therapies to patients worldwide. UCB differentiates itself by combining direct patient engagement with substantial R&D investment to address unmet needs in neurology and immunology, aiming to transform lives through science and patient care.

Company size
10,001+
Company stage
IPO
Headquarters
City of Brussels, Belgium
Founded
1928

Recently Posted Jobs

Explore more opportunities at UCB Pharma

See more jobs